My Coach Connect: An Automated Telephone-based Reporting System for Patients With Mental Illness
This trial is active, not recruiting.
|Conditions||chronic mental illness, major depression, schizophrenia, bipolar disorder|
|Treatment||my coach connect|
|Collaborator||National Institute of Mental Health (NIMH)|
|Start date||December 2012|
|End date||February 2016|
|Trial size||160 participants|
|Trial identifier||NCT01749124, P30MH082760, RHINO 2008-0132|
This is a pilot study for a novel, automated telephone system called "My Coach Connect". The purpose of the study is to evaluate the feasibility and effectiveness of this telephone tool while engaging clients and providers in discussion groups and surveys to better understand how this tool impacts the care provided and their overall experience in healthcare. Clients will use this tool to leave voice messages and survey answers which their providers will have access to by logging in to a secure website. Providers will also be able to indicate using the website whether they found a particular narrative helpful or not. Providers will have access to audio recordings of the voice responses, transcribed text of the responses, as well as "word clouds" generated from the text. Word clouds are a method of displaying the content of text such that words that are used more frequently are displayed in a larger size than words used less frequently. Clients will call in to the system approximately twice a week for a period of four months.
|Endpoint classification||efficacy study|
|Intervention model||single group assignment|
|Primary purpose||health services research|
Client and provider telephone intervention
time frame: four months
Client and provider survey
time frame: 4 months
Male or female participants at least 18 years old.
Inclusion Criteria: - Enrolled in the ROADS program - English speaking - Have a working telephone Exclusion Criteria: - Must speak english
|Official title||"My Coach Connect": Pilot Under the Partnered Research Center for Quality Care, RHINO 2008-0132|
|Principal investigator||Ken Wells, MD, MPH|
Call for more information